5.82
-0.10 (-1.69%)
-0.10 (-1.69%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cleveland BioLabs Inc | CBLI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.10 | -1.69% | 5.82 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 5.85 | 5.55 | 5.85 | 5.82 | 5.92 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 5.31 | 5.88 | 0.57 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 726 | 106,382 | $ 5.70 | $ 606,453 | 389,901 | 1.43 - 10.9718 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:01 | 267 | $ 5.82 | USD |
Cleveland BioLabs Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 75.76M | 13.02M | 6.45M | $ 1.11M | $ - | -0.23 | -19.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Cleveland BioLabs News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CBLI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 6.15 | 6.438 | 5.55 | 6.04 | 142,964 | -0.33 | -5.37% |
| 1 Month | 5.91 | 6.98 | 4.82 | 6.08 | 153,949 | -0.09 | -1.52% |
| 3 Months | 3.72 | 10.9718 | 3.49 | 6.31 | 393,550 | 2.10 | 56.45% |
| 6 Months | 2.12 | 10.9718 | 2.0777 | 3.53 | 1,560,476 | 3.70 | 174.53% |
| 1 Year | 1.59 | 10.9718 | 1.43 | 3.50 | 1,172,032 | 4.23 | 266.04% |
| 3 Years | 3.13 | 10.9718 | 0.50 | 3.41 | 493,282 | 2.69 | 85.94% |
| 5 Years | 2.41 | 10.9718 | 0.50 | 3.57 | 378,240 | 3.41 | 141.49% |
Cleveland BioLabs Description
| Cleveland BioLabs Inc is a biopharmaceutical company. The company is developing novel approaches to activate the immune system and address serious medical needs. Its proprietary platform of Toll-like immune receptor activators has applications in the mitigation of radiation injury and immuno-oncology. Its lead product candidate is entolimod, an immuno-stimulatory agent, which is developed as a radiation countermeasure and immunotherapy for oncology and other indications. Entolimod is a Toll-like receptor 5 (TLR5) agonist, which is developed as a radiation countermeasure for prevention of death from Acute Radiation Syndrome (ARS), and as an oncology drug. |
